Intravenous (IV) Equipment Market Size

Intravenous Equipment Market Size

Intravenous Equipment Market size was valued at USD 14.4 billion in 2022 and is estimated to account for USD 27.2 billion by 2032. Intravenous (IV) equipment refers to the devices, instruments, and supplies used in intravenous therapy. It includes a range of products such as IV catheters, intravenous infusion pumps, IV sets, connectors, and accessories.

To get key market trends

  Download Free Sample

IV equipment is specifically designed to facilitate the administration of fluids, medications, or nutrients directly into the patient's veins. This method allows for rapid and controlled delivery of substances into the bloodstream, ensuring efficient absorption and distribution throughout the body. IV equipment plays a critical role in healthcare settings, enabling healthcare professionals to deliver essential treatments and therapies effectively. Key factors driving the industry expansion include the rising prevalence of chronic diseases, technological advancements in novel drug delivery systems, increasing healthcare expenditure, and the demand for efficient patient care.

Surgical procedures often necessitate the use of intravenous therapy for various purposes, including fluid replacement, anesthesia administration, and post-operative pain management. With the rising number of surgeries being performed globally, there is a corresponding increase in the demand for IV equipment. Hospitals and healthcare facilities require a reliable supply of IV catheters, infusion pumps, and related equipment to support safe and efficient perioperative care. For instance, according to the National Library of Medicine, which is part of the National Institutes of Health (NIH) reports that globally, there are approximately 310 million major surgeries performed annually, with 40 to 50 million taking place in the U.S. and 20 million in Europe. Studies indicate that a small percentage, ranging from 1 to 4% of these patients may experience mortality, while up to 15% may encounter significant postoperative morbidity. Furthermore, within 30 days following surgery, a percentage of patients, ranging from 5 to 15%, may necessitate readmission.